(Q33330713)

English

Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Saturable metabolism of continuous high-dose ifosfamide with mesna and GM-CSF: a pharmacokinetic study in advanced sarcoma patients. Swiss Group for Clinical Cancer Research (SAKK) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

T Cerny

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Leyvraz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T von Briel

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Küpfer

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Schaad

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S F Schmitz

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Honegger

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C Sessa

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Brunner

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1087-1094

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-intensive chemotherapy with ifosfamide, epirubicin, and filgrastim for adult patients with metastatic or locally advanced soft tissue sarcoma: a phase II study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Dosing and side-effects of ifosfamide plus mesna

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide by continuous infusion to prevent encephalopathy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility trial of high-dose 7-day continuous-infusion ifosfamide given on an outpatient basis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesna--a short review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Dechloroethylation of ifosfamide and neurotoxicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Phenobarbital administration does not affect high-dose ifosfamide pharmacokinetics in humans

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose escalation of cyclophosphamide in patients with breast cancer: consequences for pharmacokinetics and metabolism

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Grading of neurotoxicity in cancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism and pharmacokinetics of oral and intravenous ifosfamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism of ifosfamide during a 3 day infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008386000547

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008386000547

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10572607%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33330713&oldid=1950543249"